PPT in the treatment of primary liver cancer
summary
Dad got liver cancer. Now he is in poor health. He is always nauseous. He can't eat. His face is yellow and thin. The liver often hurts. Sometimes he can't sleep because of the pain. Now it's much better. Let's share the PPT treatment of primary liver cancer, hoping to help more people.
PPT in the treatment of primary liver cancer
Treatment 1: radiotherapy, radiotherapy for the general situation is good, liver function is still good, without cirrhosis, jaundice, ascites, hypersplenism and esophageal varices, tumor is limited, there is no distant metastasis, and is not suitable for surgical resection or postoperative recurrence, can use radiotherapy based comprehensive treatment.
Treatment 2: biotherapy, mainly immunotherapy. The low immune function of patients with liver cancer has been widely confirmed, which also indicates the possibility of immunotherapy and biotherapy. Although biotherapy has shown good prospects, there are still many difficulties and problems. Sometimes, although a variety of biological response regulators can be used, several immune indexes can be expected to return to normal, but still can not completely eliminate cancer cells, or even prevent the development of tumor.
Treatment 3: the treatment of large liver cancer is not as easy as that of early liver cancer. Because in the resection of large liver cancer, it is often necessary to remove a large range of normal liver tissue, which has a great impact on liver function and high incidence of complications. More importantly, only about 10% of patients with large liver cancer are suitable for hepatectomy. Transcatheter arterial chemoembolization can control the volume of liver cancer to a certain extent, but it can also promote the metastasis of peripheral cells, so it is difficult to obtain satisfactory curative effect by simple application; it is difficult to obtain obvious curative effect by other drug treatments including immunotherapy and targeted drugs.
matters needing attention
Lettuce leaves are rich in calcium, carotene and vitamin C, while Lactuca sativa can promote the secretion of gastric juice, digestive enzymes and bile, which is helpful to increase the appetite of hepatitis B, hepatitis C virus carriers and patients with chronic liver diseases. Liver cirrhosis with anemia often eat lettuce, can promote the secretion of organic acids and enzymes, increase iron absorption, help platelet rise and recovery, prevent the deterioration of the disease.